DCGI gives nod to restricted emergency use to Serum’s Covovax for 12–17-years-old

New Delhi, Mar 9: Serum Institute’s COVID-19 vaccine Covovax has got emergency use authorisation for the 12-17 years age group subject to certain conditions from India’s drug regulator on Wednesday. Serum Institute of India CEO Adar Poonawalla, on Twitter, announced

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News